Genetic Adjuvantation of Recombinant MVA With CD40L Potentiates CD8 T Cell Mediated Immunity

Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2013.00251
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

NKG2A Blockade Potentiates CD8 T Cell Immunity Induced by Cancer Vaccines

Cell
BiochemistryGeneticsMolecular Biology
2018English

Induction of T Cell Immunity by Cutaneous Genetic Immunization With Recombinant Lentivector

Immunologic Research
Immunology
2006English

Precise Spatio-Temporal Interruption of Regulatory T Cell-Mediated CD8+ T Cell Suppression Leads to Tumor Immunity

Cancer Research
Cancer ResearchOncology
2018English

CD8+ Memory T-Cell Inflation Renders Compromised CD4+ T-Cell-Dependent CD8+ T-Cell Immunity via Naïve T-Cell Anergy

ImmunoTargets and Therapy
AllergyImmunology
2017English

Avian Influenza Viruses, Inflammation, and CD8+ T Cell Immunity

Frontiers in Immunology
AllergyImmunology
2016English

Tomatine Adjuvantation of Protective Immunity to a Major Pre-Erythrocytic Vaccine Candidate of Malaria Is Mediated viaCD8+T Cell Release of IFN-γ

Journal of Biomedicine and Biotechnology
2010English

Tumor Gene Therapy by MVA-mediated Expression of T-Cell–stimulating Antibodies

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2002English

Strikingly Poor CD8+ T-Cell Immunogenicity of Vaccinia Virus Strain MVA in BALB/c Mice

Immunology and Cell Biology
AllergyImmunologyCell Biology
2014English

Apoptotic CD8 T-Lymphocytes Disable Macrophage-Mediated Immunity to Trypanosoma Cruzi Infection

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy